American Society of Clinical Oncology Statement on the Impact of Utilization Management Policies for Cancer Drug Therapies
J Oncol Pract
.
2017 Nov;13(11):758-762.
doi: 10.1200/JOP.2017.024273.
Epub 2017 Sep 5.
Author
American Society of Clinical Oncology
PMID:
28872996
DOI:
10.1200/JOP.2017.024273
No abstract available
MeSH terms
Antineoplastic Agents / pharmacology
Antineoplastic Agents / therapeutic use*
Health Policy / trends*
Humans
Medical Oncology / methods*
Neoplasms / drug therapy*
United States
Substances
Antineoplastic Agents